Search for Clinical Trial Results
Peritoneal Fibrosis - 13 Studies Found
Status | Study |
Recruiting |
Study Name: Epigenetic Determinants of Peritoneal Fibrosis Condition: Peritoneal Fibrosis Date: 2015-07-30 |
Recruiting |
Study Name: The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate Condition: Peritoneal Fibrosis Date: 2005-09-12 |
Completed |
Study Name: Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis Condition: End Stage Renal Disease Date: 2009-03-17 Interventions:
|
Completed |
Study Name: Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF) Condition: Ultra Filtration Failure Date: 2016-06-12 Interventions: Biological: Intravenous injection Intravenous injection of stem cell or placebo to the patients with The |
Completed |
Study Name: Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis Condition: End Stage Renal Disease Date: 2014-04-30 |
Completed |
Study Name: Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients Condition:
Date: 2010-04-23 Interventions: Drug: N-acetylcysteine N-acetylcysteine (200 mg/capsule) 1200 mg/day (600 mg bid) for 6 months |
Recruiting |
Study Name: Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis Condition: Retroperitoneal Fibrosis Date: 2007-02-23 Interventions:
|
Recruiting |
Study Name: Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial Condition:
|
Recruiting |
Study Name: Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria Condition:
Date: 2017-04-13 Interventions: Other: Establish the clinical, biological and radiological characteristics of patients Establish the cli |
Completed |
Study Name: Rituximab in IgG4-related Disease: A Phase 1-2 Trial Condition:
Interventions: Drug: Rituximab Rituximab 1000 mg IV times two doses, separated by approximately 15 days. |